ERBB2 and B-cell non-Hodgkin lymphoma: Loss of DMTF1 also promotes tumorigenesis in mouse models for lymphomas [e.g., Eμ-Myc–induced B cell lymphomas (14)] and breast cancer [e.g., MMTV-neu model (15)].